Cooper Companies Inc (NYSE:COO) – Equities researchers at KeyCorp lowered their Q3 2018 EPS estimates for Cooper Companies in a report issued on Thursday. KeyCorp analyst M. Mishan now expects that the medical device company will post earnings of $2.97 per share for the quarter, down from their prior estimate of $3.02. KeyCorp currently has a “Hold” rating on the stock.
Cooper Companies (NYSE:COO) last released its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.64 by $0.01. The business had revenue of $561.50 million during the quarter, compared to the consensus estimate of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The business’s revenue was up 8.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.28 EPS.
Cooper Companies (COO) opened at $241.32 on Monday. The stock has a market capitalization of $11,812.37, a price-to-earnings ratio of 32.09, a PEG ratio of 1.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. Cooper Companies has a one year low of $186.30 and a one year high of $256.39.
Institutional investors have recently bought and sold shares of the stock. Advisory Services Network LLC increased its position in Cooper Companies by 30.6% during the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after purchasing an additional 107 shares in the last quarter. Motley Fool Asset Management LLC grew its holdings in Cooper Companies by 2.8% in the 3rd quarter. Motley Fool Asset Management LLC now owns 36,400 shares of the medical device company’s stock valued at $8,631,000 after buying an additional 1,000 shares during the period. California Public Employees Retirement System grew its holdings in Cooper Companies by 11.4% in the 3rd quarter. California Public Employees Retirement System now owns 120,582 shares of the medical device company’s stock valued at $28,591,000 after buying an additional 12,382 shares during the period. Korea Investment CORP grew its holdings in Cooper Companies by 23.9% in the 3rd quarter. Korea Investment CORP now owns 17,109 shares of the medical device company’s stock valued at $4,057,000 after buying an additional 3,300 shares during the period. Finally, Dimensional Fund Advisors LP grew its holdings in Cooper Companies by 0.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 185,979 shares of the medical device company’s stock valued at $44,525,000 after buying an additional 1,713 shares during the period. Hedge funds and other institutional investors own 96.43% of the company’s stock.
In related news, Director A Thomas Bender sold 9,150 shares of Cooper Companies stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $229.17, for a total transaction of $2,096,905.50. Following the completion of the sale, the director now owns 11,205 shares in the company, valued at approximately $2,567,849.85. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Robert S. Weiss sold 32,500 shares of Cooper Companies stock in a transaction dated Monday, December 18th. The stock was sold at an average price of $224.70, for a total value of $7,302,750.00. Following the sale, the chief executive officer now owns 119,111 shares of the company’s stock, valued at approximately $26,764,241.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,385 shares of company stock valued at $12,289,463. 1.60% of the stock is currently owned by company insiders.
The business also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Investors of record on Tuesday, January 23rd will be given a dividend of $0.03 per share. This represents a yield of 0.03%. The ex-dividend date of this dividend is Monday, January 22nd. Cooper Companies’s dividend payout ratio is presently 0.80%.
WARNING: This report was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2018/02/05/q3-2018-earnings-estimate-for-cooper-companies-inc-issued-by-keycorp-coo.html.
About Cooper Companies
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.